Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Charles River Laboratories Intl (CRL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,128,132
  • Shares Outstanding, K 47,430
  • Annual Sales, $ 1,858 M
  • Annual Income, $ 123,360 K
  • 36-Month Beta 0.68
  • Price/Sales 2.76
  • Price/Cash Flow 13.12
  • Price/Book 4.85

Price Performance

See More
Period Period Low Period High Performance
1-Month
101.58 +6.44%
on 04/06/18
111.36 -2.91%
on 03/20/18
-2.98 (-2.68%)
since 03/16/18
3-Month
96.70 +11.81%
on 02/09/18
115.65 -6.51%
on 03/13/18
+1.45 (+1.36%)
since 01/18/18
52-Week
86.66 +24.76%
on 04/25/17
119.05 -9.18%
on 11/02/17
+20.43 (+23.30%)
since 04/18/17

Most Recent Stories

More News
Charles River Laboratories Schedules First-Quarter 2018 Earnings Release and Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2018 financial results on Thursday, May 10th, before the market opens. A conference call has been scheduled...

CRL : 108.12 (+0.10%)
This Morning's Technical Outlook on Medical Research Stocks -- Bruker, Charles River Labs, DexCom, and Exact Sciences

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on BRKR, CRL, DXCM, and EXAS which can be accessed for free by signing up to www.wallstequities.com/registration....

EXAS : 47.80 (+0.25%)
BRKR : 30.47 (-0.16%)
CRL : 108.12 (+0.10%)
DXCM : 73.50 (+0.11%)
Charles River Laboratories Focuses on the Future of Oncology at AACR Annual Meeting 2018

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of oncology experts is presenting 13 scientific posters, both independently and collaboratively with...

HEMA : 6.0000 (+2.56%)
CRL : 108.12 (+0.10%)
Charles River Laboratories and PathoQuest Expand Strategic Biologics Partnership

Charles River Laboratories International, Inc. (NYSE: CRL) and PathoQuest today announced an expansion of their strategic partnership agreement to provide next-generation sequencing (NGS)...

CRL : 108.12 (+0.10%)
Charles River Laboratories Announces Closing of Senior Notes Offering

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has closed its previously announced offering of $500 million in aggregate principal amount of its 5.5% senior...

CRL : 108.12 (+0.10%)
Charles River Laboratories Completes the Acquisition of MPI Research

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of MPI Research for approximately $800 million in cash,...

CRL : 108.12 (+0.10%)
Salesforce.Com (CRM) Breaks Through Resistance at $117.06

Shares of Salesforce.Com (NYSE:CRM) opened today above their pivot of $115.68 and have already reached the first level of resistance at $117.06. Analysts will be watching for a cross of the next upside...

TMO : 219.53 (+0.60%)
CRL : 108.12 (+0.10%)
CRM : 124.46 (+0.90%)
Charles River Laboratories Announces Refinancing of Credit Facilities and Offering of $500 Million of Senior Notes

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has refinanced its existing $1.0 billion of revolving credit facility due 2021 with a new $1.55 billion...

CRL : 108.12 (+0.10%)
Charles River Laboratories Makes Expansions to Global Biologics Infrastructure

Charles River Laboratories International, Inc. (NYSE: CRL) recently announced several key expansions to its global Biologics Testing Solutions infrastructure to support the characterization,...

CRL : 108.12 (+0.10%)
Charles River La is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (CRL , ILMN , WAT , TMO , QGEN )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

ILMN : 250.00 (+0.61%)
WAT : 210.05 (+1.18%)
CRL : 108.12 (+0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Their dedicated employees are focused...

See More

Key Turning Points

2nd Resistance Point 109.75
1st Resistance Point 108.93
Last Price 108.12
1st Support Level 107.61
2nd Support Level 107.11

See More

52-Week High 119.05
Last Price 108.12
Fibonacci 61.8% 106.68
Fibonacci 50% 102.86
Fibonacci 38.2% 99.03
52-Week Low 86.66

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar